These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 26612291)

  • 21. The use of gonadotropin-releasing hormone (GnRH) agonist to induce oocyte maturation after cotreatment with GnRH antagonist in high-risk patients undergoing in vitro fertilization prevents the risk of ovarian hyperstimulation syndrome: a prospective randomized controlled study.
    Engmann L; DiLuigi A; Schmidt D; Nulsen J; Maier D; Benadiva C
    Fertil Steril; 2008 Jan; 89(1):84-91. PubMed ID: 17462639
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Is severe OHSS associated with adverse pregnancy outcomes? Evidence from a case-control study.
    Haas J; Baum M; Meridor K; Hershko-Klement A; Elizur S; Hourvitz A; Orvieto R; Yinon Y
    Reprod Biomed Online; 2014 Aug; 29(2):216-21. PubMed ID: 24934625
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased risk of preterm birth and low birthweight with very high number of oocytes following IVF: an analysis of 65 868 singleton live birth outcomes.
    Sunkara SK; La Marca A; Seed PT; Khalaf Y
    Hum Reprod; 2015 Jun; 30(6):1473-80. PubMed ID: 25883033
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ovarian hyperstimulation syndrome prevention by gonadotropin-releasing hormone agonist triggering of final oocyte maturation in a gonadotropin-releasing hormone antagonist protocol in combination with a "freeze-all" strategy: a prospective multicentric study.
    Griesinger G; Schultz L; Bauer T; Broessner A; Frambach T; Kissler S
    Fertil Steril; 2011 May; 95(6):2029-33, 2033.e1. PubMed ID: 21371705
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased early pregnancy loss in IVF patients with severe ovarian hyperstimulation syndrome.
    Raziel A; Friedler S; Schachter M; Strassburger D; Mordechai E; Ron-El R
    Hum Reprod; 2002 Jan; 17(1):107-10. PubMed ID: 11756371
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In-vitro maturation of oocytes vs in-vitro fertilization with a gonadotropin-releasing hormone antagonist for women with polycystic ovarian syndrome: can superiority be defined?
    Shavit T; Ellenbogen A; Michaeli M; Kartchovsky E; Ruzov O; Shalom-Paz E
    Eur J Obstet Gynecol Reprod Biol; 2014 Aug; 179():46-50. PubMed ID: 24965979
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ovarian hyperstimulation syndrome: steps to maximize success and minimize effect for assisted reproductive outcome.
    Gera PS; Tatpati LL; Allemand MC; Wentworth MA; Coddington CC
    Fertil Steril; 2010 Jun; 94(1):173-8. PubMed ID: 19356753
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Obstetric outcomes following ovarian hyperstimulation syndrome in IVF - a comparison with uncomplicated fresh and frozen transfer cycles.
    Ganer Herman H; Mizrachi Y; Horowitz E; Weissman A; Sabban B; Gluck O; Raziel A; Kovo M
    BMC Pregnancy Childbirth; 2022 Jul; 22(1):573. PubMed ID: 35850741
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effect of domestic highly purified urinary follicle stimulating hormone on outcomes of in vitro fertilization-embryo transfer in controlled ovarian stimulation].
    Ye H; Huang GN; Cao YX; Zhong Y; Huang YH; Zhu GJ; Zhou LM; Chen ZJ; Shi JZ; Zeng Y; Weng N; Huang XF; Yang J; Zhu YM; Li YP; Yi D; Zhuang GL
    Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):838-42. PubMed ID: 24444561
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dual trigger of oocyte maturation with gonadotropin-releasing hormone agonist and low-dose human chorionic gonadotropin to optimize live birth rates in high responders.
    Griffin D; Benadiva C; Kummer N; Budinetz T; Nulsen J; Engmann L
    Fertil Steril; 2012 Jun; 97(6):1316-20. PubMed ID: 22480822
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The optimum number of oocytes in IVF treatment: an analysis of 2455 cycles in China.
    Ji J; Liu Y; Tong XH; Luo L; Ma J; Chen Z
    Hum Reprod; 2013 Oct; 28(10):2728-34. PubMed ID: 23887075
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of live-birth defects after luteal-phase ovarian stimulation vs. conventional ovarian stimulation for in vitro fertilization and vitrified embryo transfer cycles.
    Chen H; Wang Y; Lyu Q; Ai A; Fu Y; Tian H; Cai R; Hong Q; Chen Q; Shoham Z; Kuang Y
    Fertil Steril; 2015 May; 103(5):1194-1201.e2. PubMed ID: 25813280
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preventing ovarian hyperstimulation syndrome: cabergoline versus coasting.
    Esinler I; Bozdag G; Karakocsokmensuer L
    Arch Gynecol Obstet; 2013 Nov; 288(5):1159-63. PubMed ID: 23677417
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prediction of in vitro fertilization outcome at different antral follicle count thresholds in a prospective cohort of 1,012 women.
    Jayaprakasan K; Chan Y; Islam R; Haoula Z; Hopkisson J; Coomarasamy A; Raine-Fenning N
    Fertil Steril; 2012 Sep; 98(3):657-63. PubMed ID: 22749225
    [TBL] [Abstract][Full Text] [Related]  

  • 35. GnRH agonist trigger and a freeze-all strategy to prevent ovarian hyperstimulation syndrome: a retrospective study of OHSS risk and pregnancy rates.
    Atkinson P; Koch J; Ledger WL
    Aust N Z J Obstet Gynaecol; 2014 Dec; 54(6):581-5. PubMed ID: 25476811
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The optimal length of 'coasting protocol' in women at risk of ovarian hyperstimulation syndrome undergoing in vitro fertilization.
    Nardo LG; Cheema P; Gelbaya TA; Horne G; Fitzgerald CT; Pease EH; Brison DR; Lieberman BA
    Hum Fertil (Camb); 2006 Sep; 9(3):175-80. PubMed ID: 17008270
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Comparison of the efficiency between in-vitro maturation and in-vitro fertilization after early follicular phase GnRH agonist down-regulation in infertile women with polycystic ovary syndrome].
    Zhu RR; Xiao SQ; Zhao JZ; Lin J; Wang PY; Jin CC; Jin WM
    Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):833-7. PubMed ID: 24444560
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Peak serum estradiol level during controlled ovarian hyperstimulation is associated with increased risk of small for gestational age and preeclampsia in singleton pregnancies after in vitro fertilization.
    Imudia AN; Awonuga AO; Doyle JO; Kaimal AJ; Wright DL; Toth TL; Styer AK
    Fertil Steril; 2012 Jun; 97(6):1374-9. PubMed ID: 22494926
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reduced Intellectual Ability in Offspring of Ovarian Hyperstimulation Syndrome: A Cohort Study.
    Xu GF; Zhou CL; Xiong YM; Li JY; Yu TT; Tian S; Lin XH; Liao Y; Lv Y; Zhang FH; Liu ZW; Shi YY; Shen Y; Sha J; Zhang D; Zhu YM; Sheng JZ; Huang HF
    EBioMedicine; 2017 Jun; 20():263-267. PubMed ID: 28532740
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pregnancy Outcomes of Assisted Reproductive Technology (ART) Cycle Complicated by Ovarian Hyperstimulation Syndrome (OHSS): Case Series Study.
    Alfaraj S; Alharbi AA; Aldabal HJ; Alhabib YS; AlKhelaiwi S
    Cureus; 2023 Jul; 15(7):e42303. PubMed ID: 38983799
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.